The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about the latest in bird flu and policies from the 2024 AMA Annual Meeting.
AMA Board of Trustees Chair Willie Underwood III, MD, MSc, MPH, outlines what health care organizations should do to reduce physician burnout.
Most patients wrongly believe that podiatrists are physicians. Learn with the AMA what sets orthopaedic surgeons and podiatrists apart.
Take a look at the crucial role of International Medical Graduates (IMGs) in our nation's health care landscape and how the AMA is working to support IMGs.
Precision education is a developing concept and one of four new focus areas for the AMA ChangeMedEd® initiative. Find out more.
Find information on commissions during the recruitment year.
The road to Match Day 2025 has many milestones. This guide offers insight on what to do at each step of the physician residency-selection process.
With high medical student-loan debt, doctors entering Indian Health Service face low pay. AMA calls for improving their access to loan forgiveness.
Licensing exams place big burdens on resident physicians. AMA calls for changes to Step 3 and COMLEX Level 3 to help save residents time and money.
AMA-supported prior authorization bill reintroduced in Congress and more in the latest Advocacy Update spotlight.
AMA comments on 2025 Medicare hospital inpatient payment proposed rule and more in the latest Medicare Payment Reform Advocacy Update.
The 2024 International Conference on Physician Health will be held Oct. 17–Oct. 19, 2024. Learn more.
This two-day boot camp Sept. 23-24, 2024, is designed for clinical and operational change agents looking to eliminate unnecessary work and free up more time to focus on what matters most–patient care.
Review the list of candidates to serve as AMA officers, on the Board of Trustees and councils.
Review the reports and resolutions submitted for consideration at the 2024 Annual Meeting of the AMA House of Delegates.
Download PDFs of reports on this topic from the Council on Medical Education presented during the AMA Interim and Annual Meetings.
See how the CCB recommends changes to the AMA Constitution and Bylaws and assists in reviewing the rules, regulations and procedures of AMA sections.
View candidates for upcoming elections for the International Medical Graduates Section Governing Council.
Read about candidates running for an open leadership position with the Academic Physicians Section (APS).
In the news: Body roundness index, FDA on donanemab to treat early-stage Alzheimer’s, new heart disease risk calculator and more.
Read about the process for changes to the CPT® codes and the role of the CPT Advisory Committee.
Physicians performing clinical research have responsibilities to their patients. Stay up to date on the ethics of medical research on the AMA.
Physicians performing clinical research have responsibilities to their patients. Find out how to protect the rights and safety of research participants.
Health information on the internet should be guided by the same ethical principles that apply to clinical practice. Physicians are key backstops.
Patients can hold the false belief that they might benefit directly from participating in trials. A researcher recommends ways to minimize this risk.
Physicians should become familiar with the U.S. Food and Drug Administration’s “expanded access” program so as to supply answers to patients who are seeking access to investigational therapy.
The AMA Code of Medical Ethics has guidance to help physicians navigate the tricky terrain presented by genetic engineering.
Physicians must not allow the commercial potential of a patient’s tissue to influence professional judgment.
Clinical studies have validated the use of adult stem cells in a limited number of therapies, but have yet to confirm the utility of embryonic stem cells.
Breach of confidentiality of information contained in DNA databanks may result in discrimination or stigmatization.
Physicians should not engage in research involving gene therapy or genetic engineering with human participants except under specific conditions.